EpiCept Corporation To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare ... ( TARRYTOWN N.Y. Oct. 30 /- EpiCept...)

EpiCept Corporation To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference

Date:10/30/2007

TARRYTOWN, N.Y., Oct. 30 /PRNewswire-FirstCall/ -- EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced that Jack Talley, President and CEO, will be presenting at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on November 5, 2007 at 10:15 a.m. Eastern Time at The New York Palace Hotel in New York. Mr. Talley will present a company overview.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020513/NYM112LOGO )

The presentation will be available live via webcast on November 5, 2007 and for 90 days thereafter. The webcast can be accessed by visiting http://www.epicept.com or http://www.wsw.com/webcast/rrshq12/epct.

About EpiCept Corporation

EpiCept is focused on unmet needs in the treatment of pain and cancer. EpiCept has a staged portfolio of pharmaceutical product candidates with several pain therapies in late-stage clinical trials, and a lead oncology compound (for acute myeloid leukemia, or AML) with demonstrated efficacy in a Phase III trial; a marketing authorization application for this compound has been submitted in Europe. EpiCept is based in Tarrytown, N.Y., and its research and development team in San Diego is pursuing a drug discovery program focused on novel approaches to apoptosis.

Forward-Looking Statements

This news release and any oral statements made with respect to the information contained in this news release, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include statements which express plans, anticipation, intent, contingency, goals, targets, future development and are otherwise not statements of historical fact. These statements are based on EpiCept's current expectation
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine news :

1. EpiCept Accelerates Development of Phase I Clinical Study for Cancer
2. Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines
3. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
4. Researchers Present Ways To Reduce The Risk Of Dementia
5. Researchers Present Data Regarding The Efficiency Of Herbs
6. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
7. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
8. Drug Reactions First Present Themselves In The Mouth
9. Reminiscing Into The Past Makes You Dissatisfied With The Present
10. Living In The Past Indicates Dissatisfaction With Present
11. Movies Represent Coma In A Wrong Way

Post Your Comments:

EpiCept Corporation To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare ...( TARRYTOWN N.Y. Oct. 30 /- EpiCept...),Health